234 related articles for article (PubMed ID: 38290796)
21. Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata.
Hayden MA; Ordulu Z; Gallagher CS; Quade BJ; Anchan RM; Middleton NR; Srouji SS; Stewart EA; Morton CC
Cancer Genet; 2018 Apr; 222-223():1-8. PubMed ID: 29666002
[TBL] [Abstract][Full Text] [Related]
22. A Preliminary Study: Human Fibroid Stro-1
Prusinski Fernung LE; Al-Hendy A; Yang Q
Reprod Sci; 2019 May; 26(5):619-638. PubMed ID: 29954254
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth interacting factor expression in leiomyoma compared with myometrium.
Yen-Ping Ho J; Man WC; Wen Y; Polan ML; Shih-Chu Ho E; Chen B
Fertil Steril; 2010 Aug; 94(3):1078-83. PubMed ID: 19524896
[TBL] [Abstract][Full Text] [Related]
24. Proteomic Profiling of Human Uterine Fibroids Reveals Upregulation of the Extracellular Matrix Protein Periostin.
Jamaluddin MFB; Ko YA; Kumar M; Brown Y; Bajwa P; Nagendra PB; Skerrett-Byrne DA; Hondermarck H; Baker MA; Dun MD; Scott RJ; Nahar P; Tanwar PS
Endocrinology; 2018 Feb; 159(2):1106-1118. PubMed ID: 29244110
[TBL] [Abstract][Full Text] [Related]
25. DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids.
Wei T; Geiser AG; Qian HR; Su C; Helvering LM; Kulkarini NH; Shou J; N'Cho M; Bryant HU; Onyia JE
BMC Womens Health; 2007 Apr; 7():5. PubMed ID: 17407572
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma.
Cardozo ER; Foster R; Karmon AE; Lee AE; Gatune LW; Rueda BR; Styer AK
Reprod Biol Endocrinol; 2018 May; 16(1):46. PubMed ID: 29747655
[TBL] [Abstract][Full Text] [Related]
27. Endocrine disruptor exposure during development increases incidence of uterine fibroids by altering DNA repair in myometrial stem cells.
Prusinski Fernung LE; Yang Q; Sakamuro D; Kumari A; Mas A; Al-Hendy A
Biol Reprod; 2018 Oct; 99(4):735-748. PubMed ID: 29688260
[TBL] [Abstract][Full Text] [Related]
28. Expression of erythropoietin messenger ribonucleic acid in wild-type MED12 uterine leiomyomas under estrogenic influence: new insights into related growth disparities.
Asano R; Asai-Sato M; Matsukuma S; Mizushima T; Taguri M; Yoshihara M; Inada M; Fukui A; Suzuki Y; Miyagi Y; Miyagi E
Fertil Steril; 2019 Jan; 111(1):178-185. PubMed ID: 30554729
[TBL] [Abstract][Full Text] [Related]
29. Integrated Epigenome, Exome, and Transcriptome Analyses Reveal Molecular Subtypes and Homeotic Transformation in Uterine Fibroids.
George JW; Fan H; Johnson B; Carpenter TJ; Foy KK; Chatterjee A; Patterson AL; Koeman J; Adams M; Madaj ZB; Chesla D; Marsh EE; Triche TJ; Shen H; Teixeira JM
Cell Rep; 2019 Dec; 29(12):4069-4085.e6. PubMed ID: 31851934
[TBL] [Abstract][Full Text] [Related]
30. Ethnic distribution of estrogen receptor-alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans.
Al-Hendy A; Salama SA
Fertil Steril; 2006 Sep; 86(3):686-93. PubMed ID: 16860797
[TBL] [Abstract][Full Text] [Related]
31. Quercetin and indole-3-carbinol inhibit extracellular matrix expression in human primary uterine leiomyoma cells.
Greco S; Islam MS; Zannotti A; Delli Carpini G; Giannubilo SR; Ciavattini A; Petraglia F; Ciarmela P
Reprod Biomed Online; 2020 Apr; 40(4):593-602. PubMed ID: 32276890
[TBL] [Abstract][Full Text] [Related]
32. Tissue differences in the expression of mRNAs of Ha-ras, c-myc, fos and jun in human uterine endometrium, myometrium and leiomyoma under the influence of estrogen/progesterone.
Fujimoto J; Hori M; Ichigo S; Nishigaki M; Tamaya T
Tumour Biol; 1994; 15(6):311-7. PubMed ID: 7997802
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of vitamin D receptor expression in uterine leiomyoma and nonneoplastic myometrial tissue: a cross-sectional controlled study.
Lima MSO; da Silva BB; de Medeiros ML; Dos Santos AR; do Nascimento Brazil ED; Filho WMNE; Ibiapina JO; Brito AGA; Costa PVL
Reprod Biol Endocrinol; 2021 May; 19(1):67. PubMed ID: 33952298
[TBL] [Abstract][Full Text] [Related]
34. Proteomic Analysis Identifies Tenascin-C Expression Is Upregulated in Uterine Fibroids.
Jamaluddin MFB; Nagendra PB; Nahar P; Oldmeadow C; Tanwar PS
Reprod Sci; 2019 Apr; 26(4):476-486. PubMed ID: 29730954
[TBL] [Abstract][Full Text] [Related]
35. Role of stem cells in human uterine leiomyoma growth.
Ono M; Qiang W; Serna VA; Yin P; Coon JS; Navarro A; Monsivais D; Kakinuma T; Dyson M; Druschitz S; Unno K; Kurita T; Bulun SE
PLoS One; 2012; 7(5):e36935. PubMed ID: 22570742
[TBL] [Abstract][Full Text] [Related]
36. MED12 exon 2 mutations are common in uterine leiomyomas from South African patients.
Mäkinen N; Heinonen HR; Moore S; Tomlinson IP; van der Spuy ZM; Aaltonen LA
Oncotarget; 2011 Dec; 2(12):966-9. PubMed ID: 22182697
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease.
Klemke M; Meyer A; Nezhad MH; Bartnitzke S; Drieschner N; Frantzen C; Schmidt EH; Belge G; Bullerdiek J
Genes Chromosomes Cancer; 2009 Feb; 48(2):171-8. PubMed ID: 18980243
[TBL] [Abstract][Full Text] [Related]
38. Discrepancy of uterine leiomyoma and myometrium to hypoxia-induced endoplasmic reticulum stress after uterine occlusion therapy accounts for therapeutic effect.
Xie Y; Tao X; Cheng Z; Guan Q; Yang W; Zhu Y
Arch Gynecol Obstet; 2014 May; 289(5):1039-45. PubMed ID: 24287709
[TBL] [Abstract][Full Text] [Related]
39. Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levels.
Amant F; Huys E; Geurts-Moespot A; Lindeque BG; Vergote I; Sweep F; Schoenmakers EF
J Soc Gynecol Investig; 2003 Feb; 10(2):105-9. PubMed ID: 12594000
[TBL] [Abstract][Full Text] [Related]
40. MR imaging findings of unusual leiomyoma and malignant uterine myometrial tumors: what the radiologist should know.
Fujii S; Mukuda N; Ochiai R; Yunaga H; Murakami A; Gonda T; Kishimoto M; Yamaji D; Ishibashi M
Jpn J Radiol; 2021 Jun; 39(6):527-539. PubMed ID: 33517507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]